002524.SZ
光正眼科
SZSE · Healthcare · Q 卫生 · CN
CNY 3.93
−2.48%Year over year
Reported trailing growth
- Revenue
- -4.2%
- EBITDA
- —
- EBIT
- +101.3%
- EPS
- +83.0%
- Free cash flow
- +178.8%
- Operating cash flow
- +116.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- -11.1%
- EBIT
- -21.6%
- Net income
- +88.8%
- EPS
- +88.2%
- Free cash flow
- +4.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026